Published in Infect Immun on March 01, 1992
Cholera. Clin Microbiol Rev (1995) 12.33
Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J (1995) 3.46
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc Natl Acad Sci U S A (1994) 2.68
Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. Appl Environ Microbiol (1998) 2.68
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun (1995) 2.23
Serogroup conversion of Vibrio cholerae in aquatic reservoirs. PLoS Pathog (2007) 1.98
Salmonella enterica serovar Typhimurium DT104 displays a rugose phenotype. Appl Environ Microbiol (2001) 1.37
Quorum sensing and silencing in Vibrio parahaemolyticus. J Bacteriol (2011) 1.23
The capsule polysaccharide structure and biogenesis for non-O1 Vibrio cholerae NRT36S: genes are embedded in the LPS region. BMC Microbiol (2007) 1.03
Genetic analysis of the capsule polysaccharide (K antigen) and exopolysaccharide genes in pandemic Vibrio parahaemolyticus O3:K6. BMC Microbiol (2010) 1.00
Evidence for the Adhesive Function of the Exopolysaccharide of Hyphomonas Strain MHS-3 in Its Attachment to Surfaces. Appl Environ Microbiol (1995) 0.99
Preliminary structure determination of the capsular polysaccharide of Vibrio cholerae O139 Bengal Al1837. J Bacteriol (1995) 0.98
Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis. Clin Diagn Lab Immunol (2000) 0.98
Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge. Infect Immun (1996) 0.94
Genotype and phenotypes of an intestine-adapted Escherichia coli K-12 mutant selected by animal passage for superior colonization. Infect Immun (2011) 0.94
Further characterization of Vibrio vulnificus rugose variants and identification of a capsular and rugose exopolysaccharide gene cluster. Infect Immun (2008) 0.91
vttRA and vttRB Encode ToxR family proteins that mediate bile-induced expression of type three secretion system genes in a non-O1/non-O139 Vibrio cholerae strain. Infect Immun (2010) 0.87
Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes. Clin Diagn Lab Immunol (1999) 0.85
Non-O1, non-O139 Vibrio cholerae sepsis in a patient with nephrotic syndrome. Indian J Nephrol (2013) 0.82
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
TnphoA: a transposon probe for protein export signals. Proc Natl Acad Sci U S A (1985) 21.06
Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol (1980) 10.44
The bacterial glycocalyx in nature and disease. Annu Rev Microbiol (1981) 6.98
Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41
Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae. J Bacteriol (1989) 5.85
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION. J Clin Invest (1960) 4.69
Correlation between virulence and colony morphology in Vibrio vulnificus. Infect Immun (1987) 3.93
Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect Immun (1985) 3.69
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Isolation of nonagglutinable vibrios from an enteritis outbreak in Czechoslovakia. J Infect Dis (1968) 3.26
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Opacity determinants of Neisseria gonorrhoeae: gene expression and chromosomal linkage to the gonococcal pilus gene. Cell (1984) 2.65
Spectrum of Vibrio infections in a Gulf Coast community. Ann Intern Med (1983) 2.40
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest (1990) 2.33
Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol Rev (1990) 2.31
Genetic mechanisms of bacterial antigenic variation. Microbiol Rev (1988) 2.22
The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol (1990) 2.18
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Genetics of capsular polysaccharide production in bacteria. Curr Top Microbiol Immunol (1990) 1.96
Purification and characterization of Vibrio cholerae non-O1 heat-stable enterotoxin. Infect Immun (1986) 1.89
Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum. Infect Immun (1981) 1.86
Ultrastructural study of surface components of Streptococcus suis. J Bacteriol (1990) 1.85
The biologic significance of bacterial encapsulation. Curr Top Microbiol Immunol (1990) 1.72
Non-agglutinable vibrios isolated in the 1966 epidemic of cholera in Irag. Bull World Health Organ (1969) 1.59
Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest (1979) 1.58
Specific insertion and deletion of insertion sequence 1-like DNA element causes the reversible expression of the virulence capsular antigen Vi of Citrobacter freundii in Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.44
Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans. J Infect Dis (1984) 1.27
Genetic regulation of variable Vi antigen expression in a strain of Citrobacter freundii. J Bacteriol (1981) 1.23
Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells. Infect Immun (1990) 1.20
Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun (1983) 1.20
Non-01 Vibrio cholerae infections in Cancun, Mexico. Am J Trop Med Hyg (1987) 1.17
Variation of colony morphology reflecting fimbriation in Moraxella bovis and two reference strains of M. nonliquefaciens. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.13
Non-cholera Vibrios in Sweden. Lancet (1974) 1.06
Cholera. Clin Microbiol Rev (1995) 12.33
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1999) 2.41
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans. J Infect Dis (1996) 2.17
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81
The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene. Infect Immun (1990) 1.79
Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis (1995) 1.75
Facial sweating in Horner's syndrome. Brain (1984) 1.73
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in Maryland. Am J Epidemiol (1988) 1.71
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing. Am J Trop Med Hyg (1986) 1.68
Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med (1990) 1.68
Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol (2000) 1.66
Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol (1997) 1.65
Vibrio metschnikovii bacteremia in a patient with cholecystitis. J Clin Microbiol (1981) 1.65
Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis (1993) 1.59
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun (2001) 1.58
Effect of metronidazole on hydrogen production by Clostridium acetobutylicum. Arch Mikrobiol (1972) 1.57
Spo0A directly controls the switch from acid to solvent production in solvent-forming clostridia. Mol Microbiol (2000) 1.55
Mutations in the extracellular protein secretion pathway genes (eps) interfere with rugose polysaccharide production in and motility of Vibrio cholerae. Infect Immun (2000) 1.50
The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset. Int J Neurosci (1989) 1.49
Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children. J Infect Dis (1990) 1.48
Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J Infect Dis (1993) 1.47
Use of colistin-polymyxin B-cellobiose agar for isolation of Vibrio vulnificus from the environment. Appl Environ Microbiol (1992) 1.45
Persistence of cholera in the United States: isolation of Vibrio cholerae O1 from a patient with diarrhea in Maryland. J Clin Microbiol (1986) 1.44
Chlorine and survival of "rugose" Vibrio cholerae. Lancet (1992) 1.43
Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis (2007) 1.43
Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science (1987) 1.42
Handcuff neuropathy involving the dorsal ulnar cutaneous nerve. Muscle Nerve (1993) 1.40
An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J Infect Dis (1993) 1.39
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
The biosynthesis of granulose by Clostridium pasteurianum. Biochem J (1974) 1.37
Phylogeny of Vibrio cholerae based on recA sequence. Infect Immun (2000) 1.37
Differential expression of Vibrio vulnificus capsular polysaccharide. Infect Immun (1999) 1.36
Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. J Clin Microbiol (1984) 1.35
Non-O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol (1981) 1.35
Epidemiology and spectrum of Vibrio infections in a Chesapeake Bay community. J Infect Dis (1989) 1.31
The stage is set for the diffusion of positron emission tomography (PET) in oncology. Med J Aust (1999) 1.30
Utilization of L-threnonine by a pseudomonad: a catabolic role for L-threonine aldolase. Biochem J (1969) 1.29
Purification of two Clostridium bacteriocins by procedures appropriate to hydrophobic proteins. Antimicrob Agents Chemother (1975) 1.28
Pyruvate carboxylase in Rhodopseudomonas spheroides. J Gen Microbiol (1969) 1.27
Vibrio vulnificus septicemia. Isolation of organism from stool and demonstration of antibodies by indirect immunofluorescence. Arch Intern Med (1983) 1.26
Molecular epidemiology of neonatal meningitis due to Citrobacter diversus: a study of isolates from hospitals in Maryland. J Infect Dis (1986) 1.23
The proton-translocating adenosine triphosphatase of the obligately anaerobic bacterium Clostridium pasteurianum. 1. ATP phosphohydrolase activity. Eur J Biochem (1979) 1.23
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol (1997) 1.23
Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am J Trop Med Hyg (1988) 1.22
Regeneration of protoplasts of Clostridium pasteurianum ATCC 6013. J Bacteriol (1983) 1.20
Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells. Infect Immun (1990) 1.20
Fifth Stenhous-Williams memorial lecture. Oxygen and the obligate anaerobe. J Appl Bacteriol (1976) 1.19
Proton-motive force in the obligately anaerobic bacterium Clostridium pasteurianum: a role in galactose and gluconate uptake. FEBS Lett (1975) 1.19
A video review of the diagnosis of psychogenic gait: appendix and commentary. Mov Disord (1999) 1.18
Lack of hepatic enzymatic adaptation to low and high levels of dietary protein in the adult cat. Enzyme (1977) 1.17
Carbohydrate digestion by the domestic cat (Felis catus). Br J Nutr (1977) 1.16
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun (1997) 1.15
Typhoid fever in Santiago, Chile: a study of household contacts of pediatric patients. Am J Trop Med Hyg (1984) 1.15
Clinical features of ciguatera fish poisoning: a study of the disease in the US Virgin Islands. Arch Intern Med (1982) 1.14
Use of a synthetic oligonucleotide probe to detect strains of non-serovar O1 Vibrio cholerae carrying the gene for heat-stable enterotoxin (NAG-ST). J Clin Microbiol (1990) 1.12
Zoster sine herpete of the trigeminal nerve. Oral Surg Oral Med Oral Pathol (1993) 1.12
Antibiotic therapy for Vibrio vulnificus infection. JAMA (1985) 1.11
Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland. Am J Trop Med Hyg (1999) 1.11
Growth of Vibrio vulnificus in serum from alcoholics: association with high transferrin iron saturation. J Infect Dis (1991) 1.11
Dynamics of SCR, EEG, and ERP activity in an oddball paradigm with short interstimulus intervals. Psychophysiology (1999) 1.10
Reliability of the Columbia scale for assessing signs of Parkinson's disease. Mov Disord (1993) 1.10
Clinical and neurophysiological features of tick paralysis. Brain (1997) 1.09
Carbohydrate transport in Clostridium pasteurianum. Biosci Rep (1982) 1.07